Ruediger Nave
- Physiology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology and Allergy top 5%
- Pharmacology top 10%
- Molecular Biology
- Co-authors
- Karl ZechThomas D. BethkeAnton DrollmannSteve NewmanNigel McCrackenAndrew G. SalmonRobyn L. FisherSjoerd P. van Marle
- Topics
- Asthma and respiratory diseases (17 papers)Respiratory and Cough-Related Research (9 papers)Inhalation and Respiratory Drug Delivery (8 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Ruediger Nave
20 papers receiving 728 citations
Peers
Comparison fields: 5 of 80
- Physiology 604
- Pulmonary and Respiratory Medicine 572
- Immunology and Allergy 173
- Pharmacology 43
- Molecular Biology 42
Countries citing papers authored by Ruediger Nave
This map shows the geographic impact of Ruediger Nave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger Nave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger Nave more than expected).
Fields of papers citing papers by Ruediger Nave
This network shows the impact of papers produced by Ruediger Nave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger Nave. The network helps show where Ruediger Nave may publish in the future.
Co-authorship network of co-authors of Ruediger Nave
This figure shows the co-authorship network connecting the top 25 collaborators of Ruediger Nave. A scholar is included among the top collaborators of Ruediger Nave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruediger Nave. Ruediger Nave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 22 | |
| 3 | 4 | |
| 4 | 13 | |
| 5 | 23 | |
| 6 | 14 | |
| 7 | 13 | |
| 8 | 6 | |
| 9 | 87 | |
| 10 | 31 | |
| 11 | 48 | |
| 12 | 24 | |
| 13 | 17 | |
| 14 | 32 | |
| 15 | 69 | |
| 16 | 47 | |
| 17 | 113 | |
| 18 | Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide. | 71 |
| 19 | 92 | |
| 20 | 79 |
About Ruediger Nave
Ruediger Nave is a scholar working on Immunology and Allergy, Physiology and Sensory Systems, having authored 20 papers that have together received 806 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (9 papers) and Inhalation and Respiratory Drug Delivery (8 papers). The work is most often cited by research in Immunology and Allergy (173 citations), Physiology (604 citations) and Pulmonary and Respiratory Medicine (572 citations). Ruediger Nave has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Karl Zech, Thomas D. Bethke, Anton Drollmann, Steve Newman, Nigel McCracken, Andrew G. Salmon, Robyn L. Fisher, Sjoerd P. van Marle, Shashank Rohatagi and Faith M. Williams. Their work appears in journals such as Biochemical Pharmacology, Clinical Pharmacokinetics and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.